GlassScriptPhysician profile
David Mclean Smink
NPI 1740274810
$3,666.99
in general payments reported to CMS, 2019-2025
19 companies · $491 in 2025
The $491 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $359 · 2021: $854 · 2022: $503 · 2023: $595 · 2024: $262 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $744.98 | 2019-2025 | Pangea, Iconix, Flexible Guide Pin (Stryker Acl Versitomic) |
| Ferring Pharmaceuticals INC. | $397.30 | 2019-2025 | Euflexxa |
| Medtronic, INC. | $330.58 | 2021-2024 | Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $291.07 | 2019-2020 | |
| Arthrex, INC. | $251.73 | 2021-2023 | Distal Extremities Implants Foot & Ankle Ttc Nail |
| Innovation Technologies INC | $226.14 | 2023 | Irrisept |
| Biocomposites INC | $223.91 | 2023-2025 | Stimulan |
| Supreme Orthopedic Systems, LLC | $170.67 | 2025 | |
| Globus Medical, INC. | $150.00 | 2021 | |
| Si-Bone, INC. | $144.92 | 2021 | |
| Biotissue Holdings INC. | $124.70 | 2022 | |
| Providence Medical Technology, INC. | $124.34 | 2022 | |
| Depuy Synthes Sales INC. | $116.13 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $101.82 | 2023-2025 | Zilretta, Exparel, Iovera |
| Pacira Therapeutics, INC. | $85.16 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $80.34 | 2019-2023 | Pico 7, Pico 14 |
| Fidia Pharma USA INC. | $54.78 | 2019-2025 | Hymovis, Triluron |
| Horizon Therapeutics Plc | $26.86 | 2022 | |
| Amgen INC. | $21.56 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.